Evidence for altered KP metabolism in MS first appeared in 1979 with the finding that TRP levels were significantly reduced in both plasma and CSF samples from MS patients compared with those of control subjects [Monaco et al., 1979; but see Ott et al. (1993)]. The gene discussed is NPPA; the disease is myeloid sarcoma.